SCHEMBL7814546

SCHEMBL7814546

COc1cc2c(cc1Br)n[c]n2C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
ALDH1A1 P00352 1/20 0.35
AXL P30530 1/20 0.35
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
HTR2A P28223 6/20 0.34
TSHR P16473 2/20 0.34
LMNA P02545 2/20 0.34
HTR2C P28335 2/20 0.33
TAAR1 Q96RJ0 2/20 0.33
USP2 O75604 1/20 0.33
HPGD P15428 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7814442 0.93 MEN1 (0.41) MEN1KMT2AL3MBTL1ALDH1A1AXL
SCHEMBL5982809 0.86 FGFR1 (0.39) MEN1KMT2AL3MBTL1ALDH1A1TSHR
SCHEMBL7812397 0.81 NQO2 (0.36) MEN1KMT2AL3MBTL1TSHRLMNA
SCHEMBL28763389 0.73 MEN1 (0.40) MEN1KMT2AL3MBTL1ALDH1A1AXL
SCHEMBL23702268 0.71 MEN1 (0.43) MEN1KMT2AL3MBTL1ALDH1A1AXL
SCHEMBL28763374 0.71 MAPT (0.41) MEN1KMT2AL3MBTL1ALDH1A1AXL
SCHEMBL7805200 0.70 RHEB (0.45) L3MBTL1HTR2AHTR2CMAPTMAPK1
SCHEMBL30039825 0.70 LMNA (0.49) MEN1KMT2AL3MBTL1ALDH1A1AXL
SCHEMBL25186746 0.70 NQO2 (0.41) ALDH1A1NPSR1MAPT
SCHEMBL7815337 0.69 ALDH1A1 (0.43) MEN1KMT2AL3MBTL1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0745600-B1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-10-24 EP disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 US disclosed
EP-0745600-A1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-12-04 EP disclosed